Table 1 B2AR agonists and mimics included in analyses, listed by indication
From: Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders
B2AR agonists | Total (N = 575) |
|---|---|
n (%) | |
Asthma | |
Salmeterol xinafoate/fluticasone propionate (Advair®, Advair HFA®) | 0 (0.00) |
Albuterol, albuterol sulfate (Proventil®, Ventolin®, AccuNeb®) | 47 (8.17) |
Ipratropium bromide/albuterol sulfate (Combivent®) | 0 (0.00) |
Formoterol fumarate (Foradil®, Foradil Aerolizer®) | 0 (0.00) |
Pirbuterol acetate (Maxair®) | 0 (0.00) |
Metaproterenol, metaproterenol sulfate (Alupent®, Arm-a-med® (Metapro), Metaprel®) | 2 (0.35) |
Salmeterol xinafoate (Serevent®) | 2 (0.35) |
Levalbuterol HCL (Xopenex®) | 0 (0.00) |
Pre-term labor | |
Ritodrine, ritodrine hydrochloride | 0 (0.00) |
Terbutaline, terbutaline sulfate (Brethaire®, Breathair®, Brethine®) | 55 (9.57) |